Abstract
Ureteral stents are considered of the significant revaluations in endourological practice and have become an integral part of the contemporary urologic practice. The widespread utilization of ureteric stents in children has lagged behind that in adults because of difficulties encountered for design and sizes optimization manufacturing. However, ureteral stents are considered essential tools in the management of several pediatric urological conditions ranging from, but not limited to, ureteropelvic junction obstruction (UPJO), calculi, and ureteric obstruction. The indwelling nature of ureteral stents is complicated by several unwanted effects including a feeling of pain, irritative voiding symptoms, and/or urinary tract infection. There are several potential complications in the currently utilized urinary catheters in general and ureteral stents in particular in pediatric patients.
You have full access to this open access chapter, Download chapter PDF
Similar content being viewed by others
Keywords
1 Introduction
Ureteral stents are considered of the significant revaluations in endourological practice and have become an integral part of the contemporary urologic practice. The widespread utilization of ureteric stents in children has lagged behind that in adults because of difficulties encountered for design and sizes optimization manufacturing. However, ureteral stents are considered essential tools in the management of several pediatric urological conditions ranging from, but not limited to, ureteropelvic junction obstruction (UPJO), calculi, and ureteric obstruction [1].
2 Classification of Stents
There are different indications for ureteral stents insertion, and accordingly, there is no one ideal stent. Efforts are made to provide the highest stents quality and reduce potential complications (Table 1).
The ureteral stents design comprises three significant parts; renal coil, shaft, and bladder coil (Table 2). A string may be attached to the lower end to facilitate stent removal without an additional procedure. The stent circumference ranges, and the length varies. Stents function by allowing urine flow within the stent lumen and alongside the ureteral lumen. Some different materials and designs will be discussed later in this chapter.
3 Indications of Upper Tract Drainage
The indications for stent usage in the pediatric age group are almost similar to that in adults, including relieve of obstruction that might be intrinsic or extrinsic causes, following ureteroscopy, especially complicated one, post reconstructive procedure for both upper and lower urinary tract and before shockwave lithotripsy. The most common encounters for insertion of ureteric stents in children are UPJO, calculi, and ureteric obstruction (Table 3). The double-J ureteric stent has been described to permit for efficient, reversible internalized drainage of children with primary non-refluxing megaureter (PNRM) [8].
4 Techniques of Ureteral Stenting
4.1 Insertion Approach
Ureteral stents can be inserted either retrogradely through the urethra or ante-gradely through a percutaneous tract. In children, retrograde double-J stenting seems more reliable and safer than antegrade stenting [9, 10] with greater success and lower complication rates [11, 12].
4.2 Retrograde Stenting
It is performed in a lithotomy position. Initially, starting by cystoscopy and localizing the ureteric orifice, which is then cannulated with a guidewire and open-ended ureteral catheter. A retrograde pyelogram can be obtained to examine the pelvicalyceal system and the stone. Replacement of a stiff bodied wired guidewire through the ureteral catheter and removal of the catheter. The self-retaining stent is then slide over the guidewire through the ureter under vision via a cystoscope sheath and fluoroscopy. Marks guide this along the stent that demarcates the ureteral length.
4.3 Antegrade Stenting
The guidewire is passed from the kidney through the ureter to the bladder under fluoroscopic guidance through the pre-formed percutaneous nephrostomy tract. Then, the stent is slide over the guidewire and checked its position by fluoroscopy.
5 Calculation of Stent Length
The selection of stent length is of high importance as it is needed to balance the risk between stent migration in case of using short stent versus stent irritation and stent-related pain that occurs with longer stents [13]. There are different methods to choose the most optimum length. This has been attempted by measuring the ureteral length from the UPJ to the ureteral orifice using a scaled ureteral catheter while performing pyelography [14]. Similarly, this has been tackled by measuring the length between two points; (from the center of the renal pelvis to the symphysis pubis in IVU or KUB X-ray [15]. CT scan can be utilized for the measurement by multiplying the number of slices by the interval cut the thickness of slices in the area between the renal veins to the vesicoureteric junction. A formula (stent length = age in years +10) has been introduced as a reproducible manner to predict JJ stent length irrespective of laterality or gender.
Concerning the management of ureteral stent implantation, antibiotic therapy appears to be essential to prevent infection [16], which can have rates as high as 28%.
6 The Current Problems and Limitations
The indwelling nature of ureteric stents is complicated by several unwanted effects including a feeling of pain, irritative voiding symptoms, and/or urinary tract infection (UTI). There are several potential complications in the currently utilized urinary catheters in general and ureteric stents in particular (Table 4).
The straight catheters are used to migrate downwards towards the bladder or upwards towards the kidneys. Finney was the first to introduce indwelling ureteral stents with a double J pigtail design, each pigtail coils at one end of the stent [17]. This design reduced migration and is still used nowadays. Complications encountered include upward migration in 3.3%, slipping in 4.2% (Fig. 1). High urinary tract infection with the presence of stents and catheters as considered being foreign bodies.
Complications encountered include febrile urinary tract infections in 10.8%, bacteriuria in 27.7% [18]. A recent prospective, randomized, controlled was conducted to investigate the effectiveness of continuous antibiotic prophylaxis in patients with JJ stent. The incidence of febrile urinary tract infections with CAP was significantly reduced [3.8% vs. 19% (p 0.015)]. A long stent with an extra length within the bladder cavity causes more irritation [19]. Stent irritation symptoms were found to be more if the stent crossed the midline [20].
A frequently encountered problem is the unreliability of post-operative contrast studies in the presence of the stent. This often occurs because of the inability to selectively control contrast opacification in the urinary tract that needs to be accurately tailored to each patient’s situation. Drainage of the perinephric area is often needed and mandates an extra (separate) perinephric drain (e.g., Penrose) to monitor anastomotic leakage and bleeding. This has the drawback of extra wounds and scar and discomfort at the time of removal, which is the bedside (Fig. 2).
Traditional perinephric drains lack the efficacy draining of localized or small perinephric collections and are vulnerable to dislodgement. We have introduced a double-lumen externalized ureteral stent that can drain both the urinary tract and the perinephric space and better control the area of interest during contrast studies [21] (Fig. 3).
7 Future Directions
Ureteral stents are encountering technological advancements to overcome the problems faced upon placement. Attempts to modify the traditional tube design have included changing the shape of the stent’s ends even further to inhibit migration. Moreover, integrating an antibacterial component will ultimately decrease the associated high risk of acquired urinary tract infections.
Other attempts have involved replacing the bladder end of the stent with highly flexible strands or loops to reduce the stent’s size in the bladder end to decrease the discomfort felt by a patient. In these designs, the stent may resemble a traditional tubular stent starting at the renal end and progressing for a significant distance, e.g., about 12 cm, or such a distance to start the flexible strands or loops about the iliac vessels of the patient. This significant distance was employed to prevent the migration of the stent further. Stents of this type suffer from the problem that stents of multiple sizes must be created, and then a physician must select what size stent to use based on approximations of the patient’s physiology. In addition, even with the reduced size of the strands or loops, significant patient discomfort may result [22]. Efforts are undergoing to reduce current problems related to ureteral stents placement. Specifically, for the pediatric population, an additional procedure is needed to remove the stent under general anesthesia. Magnetic tip stents were introduced to facilitate the removal without the need for another anesthesia [23, 24].
Recently, biodegradable stents are being evaluated that would typically degrade from 15 to 30 days [25]. A mixture of materials was tried to gain maximum efficiency and the least complications. The mixture allowed the stent’s gradual degradation so that the stents would dissolve from inside out and the body followed by the pigtails. This guarantees better stent stability without migration and keeps integrity till full resorption [26]. A novel design was recently introduced with an anti-reflux mechanism [27]. Likewise, coating materials would further improve the characteristics of stents and drug-eluting coating of biodegradable stents would widen the range of usage and reduce complications [28]. Antibacterial and anti-inflammatory coatings would reduce stents infection and irritation.
References
Dyer RB, Chen MY, Zagoria RJ, Regan JD, Hood CG, Kavanagh PV. Complications of ureteral stent placement. Radiographics. 2002;22:1005–22. https://doi.org/10.1148/radiographics.22.5.g02se081005.
Davenport K, Kumar V, Collins J, Melotti R, Timoney AG, Keeley FX. New ureteral stent design does not improve patient quality of life: a randomized, controlled trial. J Urol. 2011;185:175–8. https://doi.org/10.1016/j.juro.2010.08.089.
Taylor WN, McDougall IT. Minimally invasive ureteral stent retrieval. J Urol. 2002;168:2020–3. https://doi.org/10.1097/01.ju.0000033964.15384.e2.
Stoller ML, Schwartz BF, Frigstad JR, Norris L, Park JB, Magliochetti MJ. An in vitro assessment of the flow characteristics of spiral-ridged and smooth-walled JJ ureteric stents. BJU Int. 2000;85:628–31. https://doi.org/10.1046/j.1464-410x.2000.00489.x.
Mucksavage P, Pick D, Haydel D, Etafy M, Kerbl DC, Lee JY, et al. An in vivo evaluation of a novel spiral cut flexible ureteral stent. Urology. 2012;79:733–7. https://doi.org/10.1016/j.urology.2011.10.062.
Olweny EO, Portis AJ, Sundaram CP, Afane JS, Humphrey PA, Ewers R, et al. Evaluation of a chronic indwelling prototype mesh ureteral stent in a porcine model. Urology. 2000;56:857–62. https://doi.org/10.1016/s0090-4295(00)00734-2.
Wah TM, Irving HC, Cartledge J. Initial experience with the resonance metallic stent for antegrade ureteric stenting. Cardiovasc Intervent Radiol. 2007;30:705–10. https://doi.org/10.1007/s00270-007-9043-4.
Castagnetti M, Cimador M, Sergio M, De Grazia E. Double-J stent insertion across vesicoureteral junction—is it a valuable initial approach in neonates and infants with severe primary nonrefluxing megaureter? Urology. 2006;68:870–5. https://doi.org/10.1016/j.urology.2006.05.052.
Resorlu B, Sancak EB, Resorlu M, Gulpinar MT, Adam G, Akbas A, et al. Retrograde intrarenal surgery in pediatric patients. World J Nephrol. 2014;3:193–7. https://doi.org/10.5527/wjn.v3.i4.193.
Babu R, Arora A, Raj N. Stenting antegrade via veress needle during laparoscopic PyeloplastY (“SAVVY” Technique). J Indian Assoc Pediatr Surg. 2019;24:117–9. https://doi.org/10.4103/jiaps.JIAPS_38_18.
Chandrasekharam VVSS. Is retrograde stenting more reliable than antegrade stenting for pyeloplasty in infants and children? Urology. 2005;66:1301–4. https://doi.org/10.1016/j.urology.2005.06.132.
Sertic M, Amaral J, Parra D, Temple M, Connolly B. Image-guided pediatric ureteric stent insertions: an 11-year experience. J Vasc Interv Radiol. 2014;25:1265–71. https://doi.org/10.1016/j.jvir.2014.03.028.
Slaton JW, Kropp KA. Proximal ureteral stent migration: an avoidable complication? J Urol. 1996;155:58–61.
Pollack HM, Banner MP. Percutaneous nephrostomy and related pyeloureteral manipulative techniques. Urol Radiol. 1981;2:147–54. https://doi.org/10.1007/BF02926716.
Wills MI, Gilbert HW, Chadwick DJ, Harrison SC. Which ureteric stent length? Br J Urol. 1991;68:440. https://doi.org/10.1111/j.1464-410x.1991.tb15375.x.
El-Faqih SR, Hussain I. Urolithiasis in the middle east: epidemiology and pathogenesis. In The management of lithiasis. Dordrecht: Springer; 1997. p. 35–41. https://doi.org/10.1007/978-94-011-5396-6_4.
Finney RP. Experience with new double J ureteral catheter stent. J Urol. 1978;120:678–81. https://doi.org/10.1016/s0022-5347(17)57326-7.
Al-Marhoon MS, Shareef O, Venkiteswaran KP. Complications and outcomes of JJ stenting of the ureter in urological practice: a single-centre experience. Arab J Urol. 2012;10:372–7. https://doi.org/10.1016/j.aju.2012.08.004.
Rane A, Saleemi A, Cahill D, Sriprasad S, Shrotri N, Tiptaft R. Have stent-related symptoms anything to do with placement technique? J Endourol. 2001;15:741–5. https://doi.org/10.1089/08927790152596352.
Al-Kandari AM, Al-Shaiji TF, Shaaban H, Ibrahim HM, Elshebiny YH, Shokeir AA. Effects of proximal and distal ends of double-J ureteral stent position on postprocedural symptoms and quality of life: a randomized clinical trial. J Endourol. 2007;21:698–702. https://doi.org/10.1089/end.2007.9949.
Abbas TO, Ali M, Moog R. “Double-Lumen Valve-Controlled Intra-Operative Pyeloplasty Stent (VIPs)”: a new technology for post-pyeloplasty stenting—proof of concept study in a preclinical large animal model. Res Rep Urol. 2020;12:61–74. https://doi.org/10.2147/RRU.S238572.
Steven YC. Ureteral Stent Patent US8192500B2. 2019.
Mykulak DJ, Herskowitz M, Glassberg KI. Use of magnetic internal ureteral stents in pediatric urology: retrieval without routine requirement for cystoscopy and general anesthesia. J Urol. 1994;152:976–7. https://doi.org/10.1016/s0022-5347(17)32634-4.
Mitchell A, Bolduc S, Moore K, Cook A, Fermin C, Weber B. Use of a magnetic double J stent in pediatric patients: a case–control study at two Canadian pediatric centers. J Pediatr Surg. 2020;55:486–9. https://doi.org/10.1016/J.JPEDSURG.2019.03.014.
Zhang MQ, Zou T, Huang YC, Shang YF, Yang GG, Wang WZ, et al. Braided thin-walled biodegradable ureteral stent: preliminary evaluation in a canine model. Int J Urol. 2014;21:401–7. https://doi.org/10.1111/iju.12297.
Liu X, Li F, Ding Y, Zou T, Wang L, Hao K. Intelligent optimization of the film-to-fiber ratio of a degradable braided bicomponent ureteral stent. Materials (Basel, Switzerland). 2015;8:7563–77. https://doi.org/10.3390/ma8115397.
Soria F, de la Cruz JE, Budia A, Serrano A, Galan-Llopis JA, Sanchez-Margallo FM. Experimental assessment of new generation of ureteral stents: biodegradable and antireflux properties. J Endourol. 2020;34:359–65. https://doi.org/10.1089/end.2019.0493.
Yang L, Whiteside S, Cadieux PA, Denstedt JD. Ureteral stent technology: drug-eluting stents and stent coatings. Asian J Urol. 2015;2:194–201. https://doi.org/10.1016/J.AJUR.2015.08.006.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Open Access This chapter is licensed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Copyright information
© 2022 The Author(s)
About this chapter
Cite this chapter
Abbas, T., Ibrahim, T., AbdelKareem, M., Ali, M. (2022). Pediatric Ureteral Stents. In: Soria, F., Rako, D., de Graaf, P. (eds) Urinary Stents. Springer, Cham. https://doi.org/10.1007/978-3-031-04484-7_12
Download citation
DOI: https://doi.org/10.1007/978-3-031-04484-7_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-04483-0
Online ISBN: 978-3-031-04484-7
eBook Packages: MedicineMedicine (R0)